Since CD4 T cells are instrumental for overcoming experimental chronic infection and have been shown to be associated with clearance of chronic hepatitis B in patients [18,94], the concomitant induction of anti-viral CD8 and CD4 T cell immunity may be critical for vaccine efficacy. The gene discussed is CD4; the disease is chronic hepatitis B virus infection.